Search Results - "Temmoku, Junpei"

Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis by Migita, Kiyoshi, Nakamura, Minoru, Aiba, Yoshihiro, Kozuru, Hideko, Abiru, Seigo, Komori, Atsumasa, Fujita, Yuya, Temmoku, Junpei, Asano, Tomoyuki, Sato, Shuzo, Furuya, Makiko, Naganuma, Atsushi, Yoshizawa, Kaname, Shimada, Masaaki, Ario, Keisuke, Mannami, Tomohiko, Kohno, Hiroshi, Kaneyoshi, Toshihiko, Komura, Takuya, Ohira, Hiromasa, Yatsuhashi, Hiroshi

“…Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma (HCC). The…”
Get full text

Association of soluble T cell immunoglobulin domain and mucin-3 by Migita, Kiyoshi, Nakamura, Minoru, Aiba, Yoshihiro, Kozuru, Hideko, Abiru, Seigo, Komori, Atsumasa, Fujita, Yuya, Temmoku, Junpei, Asano, Tomoyuki, Sato, Shuzo, Furuya, Makiko, Naganuma, Atsushi, Yoshizawa, Kaname, Shimada, Masaaki, Ario, Keisuke, Mannami, Tomohiko, Kohno, Hiroshi, Kaneyoshi, Toshihiko, Komura, Takuya, Ohira, Hiromasa, Yatsuhashi, Hiroshi

“…Background Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma…”
Get full text

Association of soluble T cell immunoglobulin domain and mucin-3 in patients with autoimmune hepatitis by Migita, Kiyoshi, Nakamura, Minoru, Aiba, Yoshihiro, Kozuru, Hideko, Abiru, Seigo, Komori, Atsumasa, Fujita, Yuya, Temmoku, Junpei, Asano, Tomoyuki, Sato, Shuzo, Furuya, Makiko, Naganuma, Atsushi, Yoshizawa, Kaname, Shimada, Masaaki, Ario, Keisuke, Mannami, Tomohiko, Kohno, Hiroshi, Kaneyoshi, Toshihiko, Komura, Takuya, Ohira, Hiromasa, Yatsuhashi, Hiroshi

“…Background Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma…”
Get full text

Effectiveness of combination tocilizumab and glucocorticoids as an induction therapy in patients with Takayasu arteritis: An observational study by Yoshida, Shuhei, Suzuki, Eiji, Matsumoto, Haruki, Yokose, Kohei, Fujita, Yuya, Temmoku, Jumpei, Matsuoka, Naoki, Yashiro-Furuya, Makiko, Asano, Tomoyuki, Sato, Shuzo, Watanabe, Hiroshi, Migita, Kiyoshi

“…ABSTRACT Background The efficacy of tocilizumab (TCZ) in the treatment of Takayasu arteritis (TA) was demonstrated in randomized controlled trials. The…”
Get full text